An Open-label, Randomized, 6-Sequence, 3-Period Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between CJ-12420 and Clarithromycin in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 20 Dec 2016
At a glance
- Drugs Tegoprazan (Primary) ; Clarithromycin
- Indications Erosive oesophagitis; Gastro-oesophageal reflux
- Focus Pharmacokinetics
- Sponsors CJ Cheiljedang Corp.
- 13 Dec 2016 Status changed from active, no longer recruiting to completed.
- 17 Feb 2014 New trial record